Jaguar Animal Health to merge with Napo Pharmaceuticals

Merger will provide revenue stream to Jaguar from FDA-approved anti-diarrheal that offers novel mechanism of action.

Jaguar Animal Health Inc., an animal health company focused on developing and commercializing first-in-class gastrointestinal products for companion and production animals, foals and high-value horses, announced Feb. 9 that it has entered into a binding agreement of terms to merge with Napo Pharmaceuticals Inc.

All access premium subscription

This content requires a subscription to Feedstuffs in order to access. If you are a paid subscriber, use your email and password to Log In now.


Current Feedstuffs Subscribers: Online and mobile access are now included at no charge to you. To read this article, use your subscriber email and password to log-in to your account (or contact us for assistance in updating your account.)


Not Currently a Subscriber: Subscribe NOW to Feedstuffs and receive our print and/or digital publications, enewsletters and premium online content. Visit Feedstuffs.com and click on Subscribe at the top of the page for more information.


SUBSCRIBE NOW https://circulation.feedstuffs.com/Publications.aspx


TO RENEW YOUR SUBSCRIPTION https://circulation.feedstuffs.com/SubscriptionOffers.aspx


Hide comments

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish